MetaCap

Astrana Health (ASTH) vs ManpowerGroup (MAN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ManpowerGroup (MAN) has outperformed Astrana Health (ASTH) over the past year, gaining 56.4% versus a gain of 28.4%. Over five years, MAN leads with a -53.0% price change compared with -69.4% for ASTH. ManpowerGroup is the larger company by market cap ($2.04 billion vs $1.44 billion), about 1.4 times the size, while Astrana Health is growing revenue faster (+56.4% vs +0.6%).

On valuation, Astrana Health trades at a lower forward P/E (8.3x vs 9.5x for ManpowerGroup). ManpowerGroup pays a dividend yielding 3.28%, while Astrana Health does not currently pay one. Astrana Health converts more of its revenue into profit, with a net margin of 0.7% versus -0.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASTH+28.44%MAN+56.41%
+131%+52%-26%
Nov 21, 20251 yearNov 20, 2026
ASTH-74.53%MAN-55.73%
+16%-36%-88%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASTH versus MAN key metrics
MetricASTHMAN
Share price$28.90$43.95
Market cap$1.44B$2.04B
1-day change+0.77%+0.64%
YTD return+16.49%+47.83%
1-year return+28.44%+56.41%
5-year return-69.44%-53.00%
P/E ratio (TTM)26.7617.37
Forward P/E8.309.47
EPS (TTM)$1.08$2.53
Dividend yield0.00%3.28%
Annual dividend$0.00$1.44
Revenue (latest FY)$3.18B$17.96B
Revenue growth (YoY)+56.39%+0.58%
Net income (latest FY)$22.49M$-13.30M
Gross margin10.73%16.69%
Operating margin2.47%0.84%
Net margin0.71%-0.07%
52-week high$51.60$63.88
52-week low$18.08$25.15
Distance from 52-week high-43.99%-31.20%
Analyst consensusstrong_buybuy
Avg. price target upside+79.55%+18.18%
Average volume377.18K855.27K
Shares outstanding49.67M46.51M
Employees3,00025,400
SectorConsumer DiscretionaryConsumer Discretionary
IndustryProfessional ServicesProfessional Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MAN has outperformed ASTH by 28.0 percentage points over the past year.
  • Astrana Health trades at a higher earnings multiple (26.8x vs 17.4x trailing P/E).
  • ManpowerGroup offers a meaningfully higher dividend yield (3.28% vs 0.00%).
  • Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs +0.58%).

About Astrana Health

ASTH stock →

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Consumer Discretionary · Professional Services · 3,000 employees

About ManpowerGroup

MAN stock →

ManpowerGroup Inc. provides workforce solutions and services under the Manpower, the Experis, and the Talent Solutions brands in the Americas, Southern Europe, Northern Europe, and the Asia Pacific/the Middle East.

Consumer Discretionary · Professional Services · 25,400 employees

ASTH vs MAN FAQ

Which is bigger, Astrana Health or ManpowerGroup?

ManpowerGroup (MAN) is larger, with a market capitalization of $2.04B compared with $1.44B for Astrana Health (ASTH).

Which stock has performed better over the past year, ASTH or MAN?

MAN returned +56.41% over the past 12 months, compared with +28.44% for ASTH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ASTH or MAN?

MAN has the lower trailing P/E at 17.4, versus 26.8 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Astrana Health or ManpowerGroup?

ManpowerGroup pays a dividend yielding 3.28%, while Astrana Health does not currently pay a regular dividend.

Are Astrana Health and ManpowerGroup in the same industry?

Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.

More comparisons